Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news


News in brief

Sun Pharmaceutical Industries sees API sales slide in Q3

By Gareth MacDonald+



Sun Pharmaceutical Industries Ltd. saw lower active pharmaceutical ingredient (API) revenue in the third quarter of fiscal 2017.

The Indian manufacturer’s drug ingredients business generated revenue of INR3.66bn ($54.7m) in the three months to December 31 2016, down 17% on the equivalent quarter in the previous fiscal year.

Sun did not say what had caused API revenues to fall, but did say it had increased the volume of drug ingredients it supplies to its own generic pharmaceutical business.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...